Barely Significant
← all excerpts

Clinical Utility of the EpiSwitch CiRT Test to Guide Immunotherapy Across Solid Tumors: Interim Results from the PROWES Study.

Cancers (Basel) · 2025 · PMC12427751 · PMID 40940997

Europe PMCDOI
1
hedged sentence
0.0525
closest p · 1.0× alpha
0.0525
boldest claim

The sentences

borderline significantp = 0.0525so close (0.05 < p ≤ 0.1)
Lesion Measurability and CiRT Status Lesion measurability exhibited a borderline significant association with CiRT classification ( p = 0.0525).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.